Kenhara - Company finances
|
EUR
|
2019
From: 2019-06-14
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|
|
Financial data
|
|||||||
| Sales revenue | 453,871 | 4,625,763 | 4,976,334 | 6,473,161 | 5,907,610 | 4,801,377 | 5,024,576 |
| Profit before tax | 21,097 | 337,892 | 90,958 | -90,695 | 67,694 | 30,371 | -108,560 |
| Net profit | 16,882 | 280,382 | 72,051 | -93,984 | 50,253 | 14,054 | -115,834 |
| Equity | 19,382 | 299,764 | 371,815 | 277,831 | 328,084 | 311,446 | 95,612 |
| Liabilities | 391,477 | 1,221,907 | 666,241 | 1,436,705 | 1,026,136 | 1,055,663 | 1,081,670 |
| Non-current assets | 0 | 0 | 495 | 401,077 | 400,415 | 400,000 | 400,000 |
| Current assets | 410,859 | 1,521,671 | 1,037,561 | 1,313,459 | 953,805 | 967,109 | 777,282 |
| Total assets | 410,859 | 1,521,671 | 1,038,056 | 1,714,536 | 1,354,220 | 1,367,109 | 1,177,282 |
|
Taxes paid
|
|||||||
| STI taxes | - | - | - | - | - | 22,647 | 105,135 |
|
Financial indicators
|
|||||||
| Revenue change y/y | - | +919.2% | +7.6% | +30.1% | -8.7% | -18.7% | +4.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 4.1% | 18.4% | 6.9% | -5.5% | 3.7% | 1.0% | -9.8% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 87.1% | 93.5% | 19.4% | -33.8% | 15.3% | 4.5% | -121.2% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 3.7% | 6.1% | 1.4% | -1.5% | 0.9% | 0.3% | -2.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 4.6% | 7.3% | 1.8% | -1.4% | 1.1% | 0.6% | -2.2% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 20.2 | 4.1 | 1.8 | 5.2 | 3.1 | 3.4 | 11.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 453,871 | 3,469,409 | 1,866,102 | 2,157,720 | 1,969,203 | 1,600,459 | 1,674,859 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Kenhara - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2022-01-18 | 2022-02-09 | 0.02 |
| 2021-12-16 | 2022-01-10 | 0.03 |
| 2021-11-16 | 2021-12-05 | 0.03 |
| 2021-11-05 | 2021-11-08 | 0.04 |
Kenhara - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-02-21 | 2026-02-21 | 539.1 |
| 2025-03-27 | 2025-03-27 | 3401.03 |
| 2025-03-26 | 2025-03-26 | 3399.67 |
| 2025-03-07 | 2025-03-10 | 8193.15 |
| 2025-03-06 | 2025-03-06 | 7799.54 |
| 2025-03-04 | 2025-03-05 | 6833.26 |
| 2024-11-01 | 2024-11-18 | 86.14 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Kenhara, UAB, code 305189294, is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In the latest financial year, 2025, revenue increased to €5.02M, up 4.7% year on year, but the company posted a net loss of €115.8K and a negative profit margin of -2.3%. This followed a weaker 2024, when revenue fell to €4.80M from €5.91M in 2023 and net profit decreased to €14.1K from €50.3K. Over the two-year period, revenue declined by 14.9% compared with 2023, while profitability moved from modest profit to loss. At year-end 2025, total assets were €1.18M, equity €95.6K and liabilities €1.08M. The equity ratio stood at 8.1%, indicating a highly leveraged balance sheet, and asset turnover was 4.27x. Revenue per employee was €1.67M, while profit per employee was negative at -€38.6K. The latest figures show continued turnover generation, but weaker margins and reduced financial cushion in 2025.